Search company, investor...
NeoLight company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Unattributed | Alive

Total Raised


Last Raised

$2.82M | 9 mos ago

About NeoLight

NeoLight is a medical device company that engineers, designs, and manufactures technologies that treat infants with life-threatening medical conditions. The company has developed phototherapy beds to cure jaundice in pre-term and full-term babies.

NeoLight Headquarters Location

275 N. Gateway Drive

Phoenix, Arizona, 85034,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing NeoLight

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NeoLight is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,582 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

NeoLight Patents

NeoLight has filed 5 patents.

The 3 most popular patent topics include:

  • Hepatology
  • Neonatology
  • Pediatrics
patents chart

Application Date

Grant Date


Related Topics




Hepatology, Pediatrics, Neonatology, Blood tests, Rare diseases


Application Date


Grant Date



Related Topics

Hepatology, Pediatrics, Neonatology, Blood tests, Rare diseases



Latest NeoLight News

Vizient Innovative Technology Contract Awarded to NeoLight for the Skylife Neonatal Phototherapy System

Sep 6, 2022

the nation's largest member-driven health care performance improvement company. The contract was awarded based on the recommendation of the Skylife Neonatal Phototherapy System by hospital experts who serve on one of Vizient's member-led councils, and it signifies to Vizient members unique qualities that potentially enhance clinical care, patient safety, or improve business operations of health care organizations. Decrease Nurse Workload Provide for Intermittent Phototherapy which promotes Breast Feeding Success, Kangaroo Care, and Skin-to-skin time with Families. The Skylife 3D Light Array™ creates 40% body surface coverage with effective, uniform light and allows the clinician to choose between three levels of irradiance for optimal control for the care of the neonate. "We are thrilled to receive the Innovative Technology contract from Vizient, as it highlights the importance of the best-in-class technology in our Skylife Neonatal Phototherapy System," said Arik Anderson, NeoLight's CEO. "Vizient serves an important and large member base, and with this contract award, we are now even more accessible to this extensive network. We are committed to collaborating with Vizient member hospitals across the country in their mission to reduce jaundice related complications, quickly and efficiently reduce bilirubin levels and significantly reduce hospital costs." "Congratulations to NeoLight for being awarded an Innovative Technology contract," said Kelly Flaharty, senior director of contract process for Vizient. "Our member council recommended Sklife Neonatal Phototherapy System for this contract based on the efficiencies it offers and its potential to make an incremental difference in health care." Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $130 billion in annual purchasing volume. Through its Innovative Technology Program , Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle. NeoLight is a medical device company that develops empathy driven, best in class technologies for treating preventable conditions in the newborn care market. Empathy driven solutions are a framework that has the doctor-nurse-mother-infant ecosystem at the center. It fosters the emotional connection that happens, thereby providing not just treatment but also providing care. Driving neonatal care beyond the traditional hospital setting, NeoLight is also creating a robust home market to treat neonatal conditions in the home. To learn more, visit and follow us on Twitter , LinkedIn , and Facebook . SOURCE NeoLight

NeoLight Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NeoLight Rank

  • When was NeoLight founded?

    NeoLight was founded in 2014.

  • Where is NeoLight's headquarters?

    NeoLight's headquarters is located at 275 N. Gateway Drive, Phoenix.

  • What is NeoLight's latest funding round?

    NeoLight's latest funding round is Unattributed.

  • How much did NeoLight raise?

    NeoLight raised a total of $19.35M.

  • Who are the investors of NeoLight?

    Investors of NeoLight include Ben Roethlisberger, Ashley Roethlisberger, Dignity Health, HonorHealth, Paycheck Protection Program and 4 more.

  • Who are NeoLight's competitors?

    Competitors of NeoLight include D-Rev.

You May Also Like

D-Rev Logo

D-Rev exists to close the quality healthcare gap for underserved populations by designing and delivering medical technologies.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.